Jaleny Abajobir

Jaleny Abajobir practices at Wellstar Medical Group in Hiram, Georgia.

Jaleny Abajobir's NPI, 1710452875, was assigned on October 4, 2018. Jaleny Abajobir holds Georgia license RN231657.

Jaleny Abajobir's primary practice is Wellstar Medical Group, at 144 Bill Carruth Pkwy, Hiram, GA 30141 in Paulding County. The practice phone is (470) 267-2433.

Jaleny Abajobir's primary practice is Wellstar Medical Group in Hiram, Georgia. Jaleny Abajobir is also affiliated with Wellstar Paulding Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Jaleny Abajobir to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jaleny Abajobir practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Jaleny Abajobir's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Jaleny Abajobir is licensed in Georgia.

CMS counts 388 Medicare patients who saw Jaleny Abajobir in 2024. The largest group is 75 to 84, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jaleny Abajobir's median patient age at 74, with 35% women.

In 2024, Jaleny Abajobir wrote 1,308 Medicare Part D claims for 582 patients. 89% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Jaleny Abajobir for performance year 2024, reported through an alternative payment model (APM). Jaleny Abajobir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jaleny Abajobir as offering telehealth.

CMS Open Payments shows 4 general payments to Jaleny Abajobir from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $90.